(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GENESYSTEM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

GENESYSTEM

ST13

US500000079329333

Class

1, 5, 10, 42

Filing

79329333

Registration

7510039

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

04/03/2026

Trademark type

Combined

Nice classes

1, 5, 10, 42

Filing date

10/25/2021

Registration date

09/24/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/24/2024

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

03

Owner location

KR

Examiner

FALK, JONATHAN ROBERT

Law office

L40

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Genesystem Co., Ltd.

Representatives

Michael T. Smith BIRCH STEWART KOLASCH & BIRCH, LLP

Technical classification

Nice Classes

Class 1Class 5Class 10Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Diagnostic reagents for scientific or research use; reagents for scientific or medical research use; reagents for analyzing proteins for scientific or laboratory purposes; reagents for nucleic acid amplifications for scientific or laboratory purposes; reagents for extracting proteins for scientific or laboratory purposes; reagents for analyzing nucleic acid for scientific or laboratory purposes; in vitro diagnostic reagents for scientific purposes; antibody reagents for scientific purposes; reagents for scientific purposes for use in nucleic acid isolation and purification; protein synthesis chemical reagent other than for medical purposes; reagents for nucleic acid amplification other than for medical purposes; chemical reagent for extracting nucleic acid other than for medical purposes; biological preparations for use in biotechnology other than medical use; reagents for cell straining other than medical use; reagents for cell transformation other than medical use; reagents for research purposes; chemical reagents for use in genetic research; chemical reagents for genetic identity testing; diagnostic reagentsother than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis

Class 5

Reagent paper for veterinary purposes; reagents for use in veterinary genetic testing; veterinary diagnostic reagents; diagnostic agents for pharmaceutical use; diagnostic test reagents for medical or veterinary purposes; biological and chemical reagents for medical or veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; diagnostic chemical reagents for medical use; diagnostic reagents for medical or veterinary purposes; immunoassay reagents for medical use; biological reagents for medical purposes; reagents for medical use; reagent paper for medical purposes; reagents for use in medical genetic testing; medical diagnostic reagents; chemical test reagents for medical use; clinical diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes

Class 10

genetic testing apparatus for medical purposes; genetic testing apparatus for medical purposes for gene verification; miniaturized sensors for use in gene analysis and diagnosis for medical purposes; real-time gene amplification equipment for medical use; medical genetic fragment analyzers; genetic testing apparatus for medical purposes; medical genetic analyzer; biopsy forceps; diagnostic testing apparatus for medical purposes for testing whole bloodserumsputumurinefecal fecestissuecellsDNA and RNA; apparatus for taking blood samples; apparatus for DNA and RNA testing for medical purposes; DNA and RNA extraction and purification apparatus for medical purposes; medical immunoassay apparatus for testing whole bloodserumsputumurinefecal fecestissuecellsDNA and RNA; medical instruments for application in human bodiesdiagnostic kit comprised of medical diagnostic apparatus for testing for virusesbacteriafungiparasiterickettsia and protista being a pathogen ; medical apparatus for clinical diagnosis for testing whole bloodserumsputumurinefecal fecestissuecellsDNA and RNA; DNA diagnostic kit comprised of test chips for the analysis of body fluidspremix mixnuclease free waterblood sampling tubes and sealing tapes for medical purposes; clinical diagnostic kit comprised of test chips for the analysis of body fluidspremix mixnuclease free waterblood sampling tubes and sealing tapes for testing whole bloodserumsputumurinefecal fecestissuecellsDNA and RNA; patient medical monitoring instruments for monitoring DNA amplification results; medical instrumentsPCR system comprised ofmultiplex biochips for analysis of bodily fluidsdiagnostic kit comprised of medical diagnostic apparatus for testing for virusesbacteriafungiparasiterickettsia and protista being a pathogenPCR reagents; immunoadsorption columns for medical diagnostic use

Class 42

Research and development of DNA chips; DNA screening for scientific research purposes; DNA analysis for scientific research purposes; DNA sequence analysis for scientific research purposes; DNA testing services to determine paternity being laboratory services; providing information relating to scientific analysis of the genetic information via online networks; biological information check being genetic testing for scientific research purposes; biological information check being genetic testing for medical research purposes; research in the field of gene analysis; genetic fingerprinting being DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; scientific research in the fields of biomedicine; consultancy in analysis of biology sequence processing for medical research purposes; biological research; biochemical research; biotechnological research relating to industry; development of biotechnology; research and development of technology for biotechnology; multiple nucleic acid analysis for scientific research purposes; protein analysis being scientific laboratory services

Publications

History of USPTO decisions and trademark events.

33 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/22/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/27/2025

FIMP

FINAL DISPOSITION PROCESSED

02/26/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/24/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/24/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

09/24/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/09/2024

PUBO

PUBLISHED FOR OPPOSITION

07/09/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/19/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/05/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/04/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/04/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

06/04/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

12/19/2023

GNFR

FINAL REFUSAL E-MAILED

12/19/2023

CNFR

FINAL REFUSAL WRITTEN

12/19/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

06/12/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/24/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

05/24/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/20/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/20/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/20/2023

LIME

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

01/25/2023

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

11/12/2022

RFNT

REFUSAL PROCESSED BY IB

10/10/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/21/2022

RFRR

REFUSAL PROCESSED BY MPU

09/20/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/05/2022

CNRT

NON-FINAL ACTION WRITTEN

08/04/2022

DOCK

ASSIGNED TO EXAMINER

08/02/2022

MAFR

APPLICATION FILING RECEIPT MAILED

01/07/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/03/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/23/2021

Continuous trademark protection

Get notified about every new filing that threatens GENESYSTEM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.